Find uplifting stories about heroes, innovations, and solutions
3 results for "pharmaceutical access"
South Africa is partnering with Gilead Sciences to manufacture a revolutionary HIV prevention medicine that requires just two injections per year. The deal could bring affordable access to a drug that offers near-complete protection against HIV infection.
Eli Lilly just made its weight loss drug Zepbound more affordable for millions of workers by letting employers chip in on the cost. Instead of charging insurance prices, they're offering it at $449 a month with flexible employer subsidies.
Patient advocates from 30 countries are already calling on Merck to ensure its promising monthly HIV prevention pill reaches everyone who needs it. The treatment could revolutionize HIV prevention by replacing daily pills with a once-a-month option.